Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non-Current Liabilities (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Other Non-Current Liabilities data on record, last reported at $44.0 million in Q1 2025.

  • For Q1 2025, Other Non-Current Liabilities changed N/A year-over-year to $44.0 million; the TTM value through Mar 2025 reached $44.0 million, changed N/A, while the annual FY2024 figure was $52.5 million, 11.83% down from the prior year.
  • Other Non-Current Liabilities reached $44.0 million in Q1 2025 per MRVI's latest filing, down from $52.5 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $62.9 million in Q2 2023 and bottomed at $1.1 million in Q2 2021.
  • Average Other Non-Current Liabilities over 5 years is $32.0 million, with a median of $44.0 million recorded in 2025.
  • Peak YoY movement for Other Non-Current Liabilities: surged 494.94% in 2023, then decreased 11.83% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $1.6 million in 2021, then soared by 543.92% to $10.0 million in 2022, then soared by 494.94% to $59.5 million in 2023, then dropped by 11.83% to $52.5 million in 2024, then fell by 16.18% to $44.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $44.0 million in Q1 2025, $52.5 million in Q4 2024, and $54.2 million in Q3 2024.